THERAGEN ETEX Co., Ltd. engages in the manufacture and sale of pharmaceutical products and in the provision of genome sequencing services. It operates through the following business divisions: Pharmaceutical, Specialized drug distribution, Healthcare and Genome. It offers cimetidine tabs, dimetal tabs, gabamin tabs, aclfen tab, hydone tab, other pharmaceutical products and genome analysis services. The company was founded on September 27, 1990 and is headquartered in Ansan-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company